(Q42843181)

English

Weight loss induced by orlistat reverses fatty infiltration and improves hepatic fibrosis in obese patients with non-alcoholic steatohepatitis

scientific article published on March 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

Weight loss induced by orlistat reverses fatty infiltration and improves hepatic fibrosis in obese patients with non-alcoholic steatohepatitis (English)

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

steatohepatitis

0 references

0 references

author name string

Nimer Assy

1

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

Osamah Hussein

2

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

Zied Abassi

3

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

language of work or name

0 references

publication date

1 March 2007

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

56

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

3

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

443-444

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

Diet composition and the metabolic syndrome: what is the optimal fat intake?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856826

27 May 2018

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856826

27 May 2018

Nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856826

27 May 2018

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856826

27 May 2018

Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856826

16 August 2018

Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol

1 reference

https://pubmed.ncbi.nlm.nih.gov/17339254

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with orlistat reduces cardiovascular risk in obese patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17339254

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical management of obesity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17339254

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/GUT.2006.106021

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

8 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42843181&oldid=1972472711"